JP2016519938A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519938A5 JP2016519938A5 JP2016514476A JP2016514476A JP2016519938A5 JP 2016519938 A5 JP2016519938 A5 JP 2016519938A5 JP 2016514476 A JP2016514476 A JP 2016514476A JP 2016514476 A JP2016514476 A JP 2016514476A JP 2016519938 A5 JP2016519938 A5 JP 2016519938A5
- Authority
- JP
- Japan
- Prior art keywords
- way
- panel
- antibody
- cells
- specifically binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 26
- 238000000034 method Methods 0.000 claims 20
- 102100022464 5'-nucleotidase Human genes 0.000 claims 4
- 102100037241 Endoglin Human genes 0.000 claims 4
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 claims 4
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 4
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims 4
- 101000881679 Homo sapiens Endoglin Proteins 0.000 claims 4
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 4
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims 4
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 4
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims 4
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims 4
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 4
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims 4
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 3
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims 3
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims 3
- 102100025304 Integrin beta-1 Human genes 0.000 claims 3
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims 3
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 2
- 102100032912 CD44 antigen Human genes 0.000 claims 2
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 2
- 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 claims 2
- 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 claims 2
- 102100036166 C-X-C chemokine receptor type 1 Human genes 0.000 claims 1
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 claims 1
- 102000009410 Chemokine receptor Human genes 0.000 claims 1
- 108050000299 Chemokine receptor Proteins 0.000 claims 1
- 101000947174 Homo sapiens C-X-C chemokine receptor type 1 Proteins 0.000 claims 1
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims 1
- 101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 claims 1
- 102100022338 Integrin alpha-M Human genes 0.000 claims 1
- 108010018951 Interleukin-8B Receptors Proteins 0.000 claims 1
- 102000003729 Neprilysin Human genes 0.000 claims 1
- 108090000028 Neprilysin Proteins 0.000 claims 1
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 claims 1
- 102000008790 VE-cadherin Human genes 0.000 claims 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 claims 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 1
- 102000006707 alpha-beta T-Cell Antigen Receptors Human genes 0.000 claims 1
- 108010087408 alpha-beta T-Cell Antigen Receptors Proteins 0.000 claims 1
- 108010018828 cadherin 5 Proteins 0.000 claims 1
- 239000002458 cell surface marker Substances 0.000 claims 1
- 102000011778 gamma-delta T-Cell Antigen Receptors Human genes 0.000 claims 1
- 108010062214 gamma-delta T-Cell Antigen Receptors Proteins 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 230000003595 spectral effect Effects 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 238000004448 titration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1309057.6 | 2013-05-20 | ||
| GBGB1309057.6A GB201309057D0 (en) | 2013-05-20 | 2013-05-20 | Method |
| PCT/GB2014/051538 WO2014188170A1 (en) | 2013-05-20 | 2014-05-20 | Multicolor flow cytometry method for identifying a population of cells, in particular mesenchymal stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016519938A JP2016519938A (ja) | 2016-07-11 |
| JP2016519938A5 true JP2016519938A5 (enExample) | 2017-06-22 |
Family
ID=48747035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016514476A Pending JP2016519938A (ja) | 2013-05-20 | 2014-05-20 | 特定の間葉系幹細胞において、細胞の集団を同定するための、マルチカラーフローサイトメトリー方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160123980A1 (enExample) |
| EP (1) | EP2999779A1 (enExample) |
| JP (1) | JP2016519938A (enExample) |
| CN (1) | CN105378066A (enExample) |
| AU (1) | AU2014270111A1 (enExample) |
| CA (1) | CA2912984A1 (enExample) |
| EA (1) | EA201591926A1 (enExample) |
| GB (1) | GB201309057D0 (enExample) |
| HK (1) | HK1218310A1 (enExample) |
| SG (2) | SG10201709214TA (enExample) |
| WO (1) | WO2014188170A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017011549A1 (en) | 2015-07-15 | 2017-01-19 | Becton, Dickinson And Company | System and method for label selection |
| CN116359503A (zh) * | 2016-09-19 | 2023-06-30 | 血液学有限公司 | 用于使用多维分析检测异常细胞的系统、方法和制品 |
| CN106771205B (zh) * | 2017-01-18 | 2017-11-21 | 浙江博真生物科技有限公司 | 十色抗体组合物及其在白血病淋巴瘤分型中的应用 |
| WO2018155651A1 (ja) * | 2017-02-24 | 2018-08-30 | 株式会社メトセラ | 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法 |
| GB201703058D0 (en) | 2017-02-24 | 2017-04-12 | Ucl Business Plc | Biomarkers |
| CN107102127B (zh) * | 2017-04-07 | 2019-08-06 | 东北师范大学 | 一种人体外周血中单核样髓源抑制细胞的检测方法 |
| EP3399027A1 (en) * | 2017-05-04 | 2018-11-07 | Medizinische Hochschule Hannover | Stem-cell derived myeloid cells, generation and use thereof |
| WO2018207918A1 (ja) * | 2017-05-12 | 2018-11-15 | 国立大学法人 東京医科歯科大学 | 移植効率を向上させる間葉系幹細胞の純化方法 |
| CN108865987A (zh) * | 2018-07-20 | 2018-11-23 | 深圳市第二人民医院 | 一种人关节液间充质干细胞用的培养基及其制备方法 |
| EP3853610B1 (en) | 2018-09-20 | 2024-05-22 | Ventana Medical Systems, Inc. | Size-based gating to analyze flow cytometry data |
| EP4150335A4 (en) * | 2020-05-13 | 2023-06-21 | Becton, Dickinson and Company | BLOOD-BASED CONTROLS FOR A COMPLEX PANEL |
| US12487167B2 (en) * | 2020-06-26 | 2025-12-02 | Cytek Biosciences, Inc. | Methods and apparatus for full spectrum flow cytometer |
| JP7595864B2 (ja) * | 2020-07-14 | 2024-12-09 | 学校法人順天堂 | 細胞、組成物及び治療用組成物 |
| CN112147326B (zh) * | 2020-09-04 | 2022-04-08 | 北京大学 | 一种肿瘤免疫细胞亚群分型精准检测试剂盒 |
| CN112881269A (zh) * | 2021-02-23 | 2021-06-01 | 浙江正熙生物技术股份有限公司 | 一种流式荧光检测试剂的质量检测方法 |
| CN114636824A (zh) * | 2021-04-23 | 2022-06-17 | 西安康瑞道合生物科技有限公司 | 一种围产期脐带血中细胞因子和免疫细胞联合检测的试剂盒及其使用方法 |
| CN114990058A (zh) * | 2022-02-22 | 2022-09-02 | 厦门大学 | 一种脐带间充质干细胞功能亚群及其应用 |
| CN116482378A (zh) * | 2023-03-31 | 2023-07-25 | 上海吉量医药工程有限公司 | 一种检测间充质干细胞的荧光素标记抗体组合 |
| WO2024227139A1 (en) * | 2023-04-28 | 2024-10-31 | University Of Florida Research Foundation, Incorporated | Method for assessing the potency of cell populations in regenerative medicine using biomarkers |
| CN117517176B (zh) * | 2024-01-04 | 2024-03-22 | 成都棱镜泰克生物科技有限公司 | 一种流式细胞数据自动处理方法及装置 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7393656B2 (en) * | 2001-07-10 | 2008-07-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for risk stratification |
| CN102308214B (zh) * | 2008-12-12 | 2014-06-25 | 贝克曼考尔特公司 | 包含未偶联的藻胆蛋白的多色流式细胞术组合物 |
-
2013
- 2013-05-20 GB GBGB1309057.6A patent/GB201309057D0/en not_active Ceased
-
2014
- 2014-05-20 SG SG10201709214TA patent/SG10201709214TA/en unknown
- 2014-05-20 EA EA201591926A patent/EA201591926A1/ru unknown
- 2014-05-20 WO PCT/GB2014/051538 patent/WO2014188170A1/en not_active Ceased
- 2014-05-20 AU AU2014270111A patent/AU2014270111A1/en not_active Abandoned
- 2014-05-20 CN CN201480039777.7A patent/CN105378066A/zh active Pending
- 2014-05-20 SG SG11201509536WA patent/SG11201509536WA/en unknown
- 2014-05-20 CA CA2912984A patent/CA2912984A1/en not_active Abandoned
- 2014-05-20 JP JP2016514476A patent/JP2016519938A/ja active Pending
- 2014-05-20 HK HK16106235.4A patent/HK1218310A1/zh unknown
- 2014-05-20 EP EP14726726.4A patent/EP2999779A1/en not_active Withdrawn
- 2014-05-20 US US14/892,547 patent/US20160123980A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201390638A1 (ru) | Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения | |
| MX2022010686A (es) | Metodos, kits, agentes y aparatos para transduccion. | |
| HRP20180266T1 (hr) | Postupak priprave osnovnog medija za kulturu mezenhimnih matičnih stanica, osnovni medij za kulturu mezenhimnih matičnih stanica, te terapijsko sredstvo za stanice koje se uzgaja i diferencira uz njegovu upotrebu | |
| JP2010506563A5 (enExample) | ||
| PE20190229A1 (es) | Anticuerpos anti-fcrn | |
| WO2011062634A3 (en) | Monoclonal antibodies and diagnostic uses thereof | |
| WO2013086429A3 (en) | Methods and compositions for classification of samples | |
| WO2013059293A9 (en) | Single, direct detection of hemoglobin a1c percentage using enzyme triggered redox altering chemical elimination (e-trace) immunoassay | |
| MX2014011503A (es) | Metodos de pronostico, diagnostico y tratamiento de la fibrosis pulmonar idiopatica. | |
| WO2016054603A3 (en) | Multivalent meditopes, meditope-binding antibodies and uses thereof | |
| MX2011003855A (es) | Metodos para producir anticuerpos a partir de celulas plasmaticas. | |
| BR112012022775A2 (pt) | composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas | |
| MX2011010012A (es) | NUEVOS ANTICUERPOS ANTI-A5ß1 Y SUS USOS. | |
| JP2014506118A5 (enExample) | ||
| EA201791610A1 (ru) | Проникающие в клетку антитела | |
| WO2012071216A3 (en) | Antibodies for tumor gangliosides | |
| PH12013502490A1 (en) | Lysyl oxidase-like 2 assay and methods of use thereof | |
| MX380687B (es) | Metodo para preparar células troncales con pluripotencia inducida a partir de células troncales mesenquimatosas utilizando una fracción de florotanino. | |
| EP2808815A3 (en) | Identification of biologically and clinically essential genes and gene pairs, and methods employing the identified genes and gene pairs | |
| WO2014177867A3 (en) | Differentially expressed biomarkers for alzheimer's disease | |
| JP2016063801A5 (enExample) | ||
| EA201691091A1 (ru) | Диагностические реагенты для улучшенной in vivo или in vitro клеточно-опосредованной иммунологической диагностики туберкулеза | |
| WO2013150375A3 (en) | Endothelial cells activation biomarkers characterizing antibody mediated rejection and uses thereof | |
| WO2011159741A3 (en) | Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same | |
| WO2011160132A3 (en) | Detection of epha3 as a marker of the presence of a solid tumor |